Gentler chemo combo offers hope for elderly lung cancer patients
NCT ID NCT07020065
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is for people aged 70 and older with advanced non-small cell lung cancer who are too frail for standard chemotherapy. It compares a lower-dose chemo plus an immunotherapy drug (cemiplimab) against immunotherapy alone. The goal is to find a treatment that works well but causes fewer side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
EOC Istituto Oncologico della Svizzera Italiana (IOSI)
RECRUITINGViganello, 6962, Switzerland
-
HFR Fribourg
RECRUITINGFribourg, Villars-sur-Glâne, 1752, Switzerland
-
Hôpital du Valais - Sion
RECRUITINGSion, 1951, Switzerland
-
Hôpitaux Universitaires de Genève
RECRUITINGGeneva, 1211, Switzerland
-
Inselspital
RECRUITINGBern, 3010, Switzerland
-
KSW Kantonsspital Winterthur
RECRUITINGWinterthur, 8401, Switzerland
-
Kantonsspital - St. Gallen
RECRUITINGSankt Gallen, CH-9007, Switzerland
-
Kantonsspital Aarau
RECRUITINGAarau, CH-5001, Switzerland
-
Kantonsspital Baden
RECRUITINGBaden, 5404, Switzerland
-
Kantonsspital Baselland
RECRUITINGBruderholz, 4101, Switzerland
-
Kantonsspital Graubuenden
RECRUITINGChur, CH-7000, Switzerland
-
Kantonsspital Olten - Solothurner Spitäler
RECRUITINGOlten, 4600, Switzerland
-
Kantonsspital Winterthur
RECRUITINGWinterthur, 8401, Switzerland
-
Spital Thun
RECRUITINGThun, 3600, Switzerland
-
Spital Thurgau AG - Kantonsspital Frauenfeld
RECRUITINGFrauenfeld, 8501, Switzerland
-
Stadtspital Zürich Triemli
RECRUITINGZurich, 8063, Switzerland
-
Universitätsspital Basel
RECRUITINGBasel, 4031, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New drug XTX501 takes aim at Hard-to-Treat cancers
- New drug cocktail targets Hard-to-Treat lung cancer
- Zapping resistant spots: radiation may buy more time for lung cancer patients on targeted drugs
- New hope for Hard-to-Treat lung cancer: targeted drug combo shows promise
- Simple blood test may predict immunotherapy success in lung cancer
- New platform aims to predict lung cancer treatment success